Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2025-04-11 Transaction in Own Shar…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Medistim ASA – Status on share buyback
Transaction in Own Shares Classification · 100% confidence The document is titled 'Medistim ASA – Status on share buyback' and explicitly details the number of shares purchased by the company during a specific period (March 11, 2025, through April 11, 2025) as part of a previously announced repurchase program. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers company buybacks. The document provides transaction details, aggregated volumes, and the resulting holding of own shares. It is not a general regulatory announcement (RNS) because it is highly specific to a corporate action (share repurchase), nor is it an announcement of a report (RPA).
2025-04-11 English
Notice of Annual General Meeting in Medistim ASA
AGM Information Classification · 99% confidence The document is explicitly titled 'NOTICE OF ORDINARY GENERAL MEETING' and details the agenda for this meeting, which includes items like approval of the annual report, dividend distribution, election of Board Members, and approval of various authorizations (share capital increase, share purchase). Furthermore, it includes a detailed 'POWER OF ATTORNEY ORDINARY GENERAL MEETING' form for shareholders to vote by proxy. This content is characteristic of materials distributed to shareholders in preparation for an Annual General Meeting (AGM). While it mentions the 'Annual report for 2024' as an attachment (Item 3), the primary document itself is the notice and proxy material for the meeting, fitting the 'AGM Information' category.
2025-04-10 English
Notice of Annual General Meeting in Medistim ASA
Annual Report Classification · 100% confidence The document is explicitly titled 'CORPORATE ANNUAL REPORT 2024' and contains comprehensive sections including a letter from the CEO, Board of Directors report, corporate governance, sustainability report, and full consolidated financial statements for the group and parent company. It covers the fiscal year 2024 and provides detailed operational and financial reviews, fitting the definition of an Annual Report (10-K). FY 2024
2025-04-10 English
Notice of Annual General Meeting in Medistim ASA
Annual Report Classification · 100% confidence The document is titled 'Medistim ASA CORPORATE ANNUAL REPORT 2024' and contains detailed sections typical of an annual report, including a letter from the CEO, board of directors report, corporate governance report, sustainability report, and consolidated financial statements. It covers the full fiscal year 2024 and includes comprehensive financial data, operational review, governance, risk factors, and outlook. The length is substantial (15,000 characters) and it is not merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2024
2025-04-10 Norwegian
Notice of Annual General Meeting in Medistim ASA
AGM Information Classification · 98% confidence The document explicitly announces the 'Notice of Annual General Meeting in Medistim ASA' and provides the date, time, and location for the meeting. It also mentions that the agenda, voting form, and the annual report for 2024 are attached. Since this document is a notice calling for the AGM and mentioning the attached materials, it fits the definition of AGM Information (AGM-R). Although it mentions the annual report is attached, the primary purpose and title of this specific filing is the AGM notice itself, making AGM-R the most precise classification over RPA or 10-K.
2025-04-10 English
Board approval of the 2024 Financial statements for Medistim ASA
Annual Report Classification · 100% confidence The document is titled 'Medistim ASA CORPORATE ANNUAL REPORT 2024' and contains detailed sections typical of an annual report, including a letter from the CEO, board of directors report, corporate governance report, sustainability report, and consolidated financial statements. It covers the full fiscal year 2024 and includes comprehensive financial data, operational review, risk factors, outlook, and governance information. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K). FY 2024
2025-04-08 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.